These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10523390)

  • 1. State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle.
    Tallant EA; Diz DI; Ferrario CM
    Hypertension; 1999 Oct; 34(4 Pt 2):950-7. PubMed ID: 10523390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury.
    Strawn WB; Ferrario CM; Tallant EA
    Hypertension; 1999 Jan; 33(1 Pt 2):207-11. PubMed ID: 9931106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth.
    Freeman EJ; Chisolm GM; Ferrario CM; Tallant EA
    Hypertension; 1996 Jul; 28(1):104-8. PubMed ID: 8675248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
    Hayashi N; Yamamoto K; Ohishi M; Tatara Y; Takeya Y; Shiota A; Oguro R; Iwamoto Y; Takeda M; Rakugi H
    Hypertens Res; 2010 Nov; 33(11):1182-5. PubMed ID: 20703229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease.
    Nakano N; Morishita R; Moriguchi A; Nakamura Y; Hayashi SI; Aoki M; Kida I; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1998 Sep; 32(3):444-51. PubMed ID: 9740609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells.
    Clark MA; Diz DI; Tallant EA
    Hypertension; 2001 Apr; 37(4):1141-6. PubMed ID: 11304516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative action of an angiotensin I-converting enzyme inhibitory peptide, Val-Tyr, via an L-type Ca2+ channel inhibition in cultured vascular smooth muscle cells.
    Toshiro M; Ueno T; Tanaka M; Oka H; Miyamotq T; Osajima K; Matsumoto K
    Hypertens Res; 2005 Jun; 28(6):545-52. PubMed ID: 16231761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways.
    Touyz RM; Schiffrin EL
    Hypertension; 1997 Aug; 30(2 Pt 1):222-9. PubMed ID: 9260984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
    Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T
    J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury.
    Nozawa Y; Matsuura N; Miyake H; Yamada S; Kimura R
    Life Sci; 1999; 64(22):2061-70. PubMed ID: 10374931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein kinase activity regulation role of angiotensin and endothelin systems in vascular smooth muscle cells.
    Kubo T; Ibusuki T; Chiba S; Kambe T; Fukumori R
    Eur J Pharmacol; 2001 Jan; 411(1-2):27-34. PubMed ID: 11137855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system.
    Roks AJ; van Geel PP; Pinto YM; Buikema H; Henning RH; de Zeeuw D; van Gilst WH
    Hypertension; 1999 Aug; 34(2):296-301. PubMed ID: 10454457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan.
    Iyer SN; Chappell MC; Averill DB; Diz DI; Ferrario CM
    Hypertension; 1998 Feb; 31(2):699-705. PubMed ID: 9461243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular smooth muscle polyploidy in genetic hypertension: the role of angiotensin II.
    Devlin AM; Davidson AO; Gordon JF; Campbell AM; Morton JJ; Reid JL; Dominiczak AF
    J Hum Hypertens; 1995 Jun; 9(6):497-500. PubMed ID: 7473534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells.
    Haxsen V; Adam-Stitah S; Ritz E; Wagner J
    Circ Res; 2001 Mar; 88(6):637-44. PubMed ID: 11282899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of vascular smooth-muscle cell growth by angiotensin II.
    Pratt RE
    Blood Press Suppl; 1996; 2():6-9. PubMed ID: 8913533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-(1-7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells.
    Zhang F; Li S; Song J; Liu J; Cui Y; Chen H
    Atherosclerosis; 2017 Jun; 261():90-98. PubMed ID: 28283184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro.
    Herbert JM; Delisée C; Dol F; Schaeffer P; Cazaubon C; Nisato D; Chatelain P
    Eur J Pharmacol; 1994 Jan; 251(2-3):143-50. PubMed ID: 8149971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin-converting enzyme inhibition on arterial, venous and capillary functions in cat skeletal muscle in vivo.
    Ekelund U
    Acta Physiol Scand; 1996 Sep; 158(1):29-37. PubMed ID: 8876745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human-derived vascular smooth muscle cells produce angiotensin II by changing to the synthetic phenotype.
    Hu WY; Fukuda N; Ikeda Y; Suzuki R; Tahira Y; Takagi H; Matsumoto K; Kanmatsuse K; Mugishima H
    J Cell Physiol; 2003 Aug; 196(2):284-92. PubMed ID: 12811821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.